Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Quinn

Showing results (81-90 of 255) with videos related to

Pageof 26
Sort By:
The Journal of Urology|January 7, 2022
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 CasesAnirban P Mitra, Jie Cai, Gus Miranda, et al.
Microbial Genomics|May 21, 2024
Genomic analysis of an outbreak of Shiga toxin-producing <i>Escherichia coli</i> O183:H18 in the United Kingdom, 2023David R Greig, Orlagh I Quinn, Ella V Rodwell, et al.
Cancers|November 12, 2013
Immune response to sipuleucel-T in prostate cancerEddie Thara, Tanya B Dorff, Monica Averia-Suboc, et al.
Biology Open|July 23, 2020
Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathwaysGrace X Li, Shaobing Zhang, Ren Liu, et al.
Cancer Treatment and Research Communications|December 12, 2018
Impact of timing of administration of bone supportive therapy on pain palliation from radium-223Kelly Khai-Li Yap, William Wong, Lingyun Ji, et al.
Clinical Genitourinary Cancer|September 30, 2017
Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer PatientsJanice M Loh, Adrienne L Tran, Lingyun Ji, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancerA W Tolcher, D I Quinn, A Ferrari, et al.
Urology|November 19, 2013
Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 casesAlev Brown, Yanling Ma, Kathleen Danenberg, et al.
Nature Reviews. Urology|November 13, 2019
Radium-223 mechanism of action: implications for use in treatment combinationsMichael J Morris, Eva Corey, Theresa A Guise, et al.
Cancer|May 1, 1999
Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experienceM J Veness, D I Quinn, C S Ong, et al.
Pageof 26

Showing results (81-90 of 255) with videos related to

Sort By:
Pageof 26
The Journal of Urology|January 7, 2022
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 CasesAnirban P Mitra, Jie Cai, Gus Miranda, et al.
Microbial Genomics|May 21, 2024
Genomic analysis of an outbreak of Shiga toxin-producing <i>Escherichia coli</i> O183:H18 in the United Kingdom, 2023David R Greig, Orlagh I Quinn, Ella V Rodwell, et al.
Cancers|November 12, 2013
Immune response to sipuleucel-T in prostate cancerEddie Thara, Tanya B Dorff, Monica Averia-Suboc, et al.
Biology Open|July 23, 2020
Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathwaysGrace X Li, Shaobing Zhang, Ren Liu, et al.
Cancer Treatment and Research Communications|December 12, 2018
Impact of timing of administration of bone supportive therapy on pain palliation from radium-223Kelly Khai-Li Yap, William Wong, Lingyun Ji, et al.
Clinical Genitourinary Cancer|September 30, 2017
Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer PatientsJanice M Loh, Adrienne L Tran, Lingyun Ji, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancerA W Tolcher, D I Quinn, A Ferrari, et al.
Urology|November 19, 2013
Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 casesAlev Brown, Yanling Ma, Kathleen Danenberg, et al.
Nature Reviews. Urology|November 13, 2019
Radium-223 mechanism of action: implications for use in treatment combinationsMichael J Morris, Eva Corey, Theresa A Guise, et al.
Cancer|May 1, 1999
Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experienceM J Veness, D I Quinn, C S Ong, et al.
Pageof 26